Minrad and Piramal to Merge
Piramal Healthcare Limited will acquire Minrad International for $.12 per share plus the assumption of debt. The total transaction, valued […]
Read more »NovaDel: Longs May Finally Get a Good Night’s Sleep
The FDA has approved NovaDel’s Zolpimist, an oral spray for the short-term treatment of insomnia. Zolpimist contains zolpidem tartrate, the […]
Read more »[Incubator Profile] UAMS BioVentures
OneMedPlace would like to welcome UAMS BioVentures as a founding member of our Portfolio Development Group. BioVentures, will discuss its […]
Read more »[Company Profile] OptiNose
OptiNose’s breath-actuated devices deliver intranasal drugs to targeted regions of the nasal cavity, including the sinuses and the olfactory region, […]
Read more »AngioDynamics’ NanoKnife: “Unique and Remarkable” Absence of Post-Operative Pain
AngioDynamics announced the use of its Irreversible Electroporation (IRE) technology on a lymph node metastasis and the first lung lesion […]
Read more »CompuMed Secures $4 Million for Strategic Initiatives
CompuMed has secured a $4 million line of credit, allowing the telemedicine company to pursue strategic initiatives even in this […]
Read more »Citing a Lack of Funds, PLC Systems Defers RenalGuard Trial
It’s been over 18 months since PLC Systems enrolled the first patients in its RenalGuard clinical trial. It now appears […]
Read more »Synthes Prevails Against Medtronic
Synthes, a maker of spine and bone implants, has prevailed in a court battle with device-giant Medtronic. Synthes alleged that […]
Read more »Synergetics USA: Shift in Corporate Strategy Yields Strong First Quarter Results
Synergetics USA reported first quarter revenues of $12.2 million, an increase of 17% over the year ago period. More compelling […]
Read more »Patient Enrollment for Monovisc U.S. Clinical Trial Complete
Anika Therapeutics, a developer of products for tissue protection, healing and repair, has completed patient enrollment for its Monovisc U.S. […]
Read more »